CompletedPhase 2

Beta Glucan 500 and Biological Age and Immune Age

United States60 participantsStarted 2025-05-14

Plain-language summary

The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Beta Glucan 500 on a variety of validated markers of biological and immune age on the comprehensive TruAge panel (TruDiagnostics, Lexington, KY).

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult females or males age ≥ 40 years
✓. Ability to read and speak English
✓. Previous completion of a TruDiagnostic TruAge test within the past three months to enable comparison of previous biomarkers to the same biomarkers after intervention
✓. DunedinPACE estimate of aging \>0.9

Exclusion criteria

✕. Current diagnosis and treatment for an autoimmune condition
✕. Current use of beta-glucan or mushroom dietary supplement
✕. Known allergies to beta glucan, yeast, or mushrooms
✕. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
✕. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
✕. Participants unable to provide consent

What they're measuring

Epigenetic Testing

Timeframe: Change from baseline to 12 weeks

Trial details

NCT IDNCT07104929

SponsorOvationLab

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2025-10-09

View on ClinicalTrials.gov More Aging trials